Metabolic Genetics and Newborn Screening
Effective July 1, 2009, Arkansas implemented advanced newborn screening. As of this date, all newborns in the state receive screening by tandem mass spectrometry (MS/MS) which covers over 25 metabolic disorders of amino acids, organic acids and fatty acids.
In addition, newborns are screened for:
- Biotinidase deficiency.
- Congenital adrenal hyperplasia (CAH).
- Cystic fibrosis (CF).
- Hearing loss.
This program has several integrated components that represent a collaborative effort among multiple agencies to make a seamless flow of screening, confirmatory testing, contact, management and follow up. The major components of this program include:
- Arkansas State Laboratory – The State Laboratory performs all first tier new born screening (except hearing loss).
- Hearing Loss.
- Arkansas Department of Health – Coordinates testing and follow up.
- Arkansas Children’s Hospital – Performs confirmatory (second tier) testing for MS/MS screening, CAH, and CF.
For an Appointment
8:00 a.m. – 4:30 p.m.
Monday – Friday
Freeway Medical Tower, 6th floor, Suite 605